115 related articles for article (PubMed ID: 212917)
1. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
Kennedy AL; Sheridan B; Montgomery DA
Acta Endocrinol (Copenh); 1978 Nov; 89(3):461-8. PubMed ID: 212917
[TBL] [Abstract][Full Text] [Related]
2. The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
Whitehead HM; Beacom R; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1990 Feb; 32(2):193-201. PubMed ID: 2161298
[TBL] [Abstract][Full Text] [Related]
3. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
4. Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
Boscaro M; Benato M; Mantero F
Clin Endocrinol (Oxf); 1983 Oct; 19(4):485-91. PubMed ID: 6313262
[TBL] [Abstract][Full Text] [Related]
5. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
Atkinson AB; Kennedy AL; Sheridan B
Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
[TBL] [Abstract][Full Text] [Related]
6. Cushing's disease: clinical and laboratory response to bromocriptine therapy.
de Pinho MO; Antunes RC; Lima MB; Francalanci CC; Franco S
J Endocrinol Invest; 1984 Dec; 7(6):585-8. PubMed ID: 6099377
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
O'Mullane N; Walker B; Jefferson J; Hipkin L; Diver M; Davis C
J Endocrinol Invest; 1978 Oct; 1(4):355-7. PubMed ID: 229153
[TBL] [Abstract][Full Text] [Related]
8. Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine.
Adachi M; Takayanagi R; Yanase T; Sakai Y; Ikuyama S; Nakagaki H; Osamura Y; Sanno N; Nawata H
Intern Med; 1996 Mar; 35(3):207-11. PubMed ID: 8785455
[TBL] [Abstract][Full Text] [Related]
9. A case of Cushing's disease successfully treated with bromocriptine.
Sumiya N; Hiramatsu K; Arimori S
Jpn J Med; 1990; 29(2):185-90. PubMed ID: 2172607
[TBL] [Abstract][Full Text] [Related]
10. Long term bromocriptine therapy in Cushing's disease.
Kapcala LP; Jackson IM
J Endocrinol Invest; 1982; 5(2):117-20. PubMed ID: 6284830
[TBL] [Abstract][Full Text] [Related]
11. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease.
Mercado-Asis LB; Yasuda K; Murayama M; Mune T; Morita H; Miura K
Endocrinol Jpn; 1992 Aug; 39(4):385-95. PubMed ID: 1332855
[TBL] [Abstract][Full Text] [Related]
13. Effect of injectable bromocriptine in patients with Cushing's disease.
Invitti C; De Martin M; Danesi L; Cavagnini F
Exp Clin Endocrinol Diabetes; 1995; 103(4):266-71. PubMed ID: 7584534
[TBL] [Abstract][Full Text] [Related]
14. [Unique type of Cushing's disease in clinical profile: cyclic Cushing's syndrome and Cushing's disease with favorable outcome to a high daily dose of bromocriptine].
Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):11-6. PubMed ID: 7958078
[TBL] [Abstract][Full Text] [Related]
15. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
16. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
17. Reduction of pituitary tumor size with clinical and biochemical improvement with bromocriptine in a normoprolactinemic Cushing's disease.
Hayashi H; Mercado-Asis LB; Murayama M; Yamakita N; Yasuda K; Miura K
Endocrinol Jpn; 1990 Dec; 37(6):875-82. PubMed ID: 1966282
[TBL] [Abstract][Full Text] [Related]
18. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
19. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
20. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]